Sodium ionophore converts growth manner of vascular smooth muscle cells from spontaneously hypertensive rats. 1996

T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
Second Department of Internal Medicine, Hirosaki University School of Medicine, Japan.

OBJECTIVE Vasoconstrictor peptides such as endothelin (ET) cause hypertrophy of vascular smooth muscle cells (VSMC) in Wistar Kyoto rats (WKY) and hyperplasia in spontaneously hypertensive rats (SHR). They also induce an increase in Na+ concentration ([Na+]i) and activate protein kinase C (PKC) independently. Therefore, we tested the hypothesis that the increase in [Na+]i may be involved in the conversion of growth manner under activated PKC in SHR VSMC. RESULTS 10(-7) M phorbol ester (TPA) increased the diameter and protein content of VSMC from both strains under 18% serum conditions. Further addition of 10(-6) M gramicidin (Na+ ionophore) converted TPA-induced hypertrophy to hyperplasia, which was due to the quick transition from S to G2/M phase, only in SHR VSMC. Western blot analysis showed that serum- and TPA-induced tyrosine phosphorylation of mitogen-activated protein (MAP) kinase was potentiated by 10(-6) M gramicidin in SHR. [Na+]i, which was measured by sodium-binding benzofuran isophthalate (SBFI), was increased about 35 mM by 10(-6) M gramicidin in both strains, but TPA did not affect basal [Na+]i and the gramicidin-induced increase in [Na+]i. CONCLUSIONS We conclude that sodium ionophore may convert hypertrophy to hyperplasia synergistically with activated PKC in SHR VSMC, possibly by MAP kinase phosphorylation.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007476 Ionophores Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channels across membranes. Many are antibiotics, and many act as uncoupling agents by short-circuiting the proton gradient across mitochondrial membranes. Ionophore
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats

Related Publications

T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
June 1994, Clinical science (London, England : 1979),
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
May 1991, Clinical and experimental pharmacology & physiology,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
February 1995, American journal of hypertension,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
March 1993, Scanning microscopy,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
October 2003, Clinical and experimental hypertension (New York, N.Y. : 1993),
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
January 1984, Journal of cardiovascular pharmacology,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
January 1979, Blood vessels,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
January 1988, Heart and vessels,
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
January 1981, Hypertension (Dallas, Tex. : 1979),
T Osanai, and T Kanazawa, and T Okuguchi, and T Kamada, and H Metoki, and Y Oike, and K Onodera
August 1989, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!